Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Depression 2Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Breast Neoplasms 1Breast Cancer Surgery 1Anxiety Disorders 1

Interventions

Temozolomide 7Carboplatin 4Vincristine 3Surveys and Questionnaires 3Radiotherapy 3Magnetic Resonance Imaging 3Bevacizumab 3Vorinostat 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Etoposide 2Disulfides 2veliparib 1tozuleristide 1romidepsin 1lonafarnib 1ispinesib 1etoposide phosphate 1emvododstat 1cediranib 1Valproic Acid 1Thiotepa 1Standard of Care 1Saline Solution 1Radiosurgery 1Radiation 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Spinal Cord Neoplasms × Esketamine × Clear all
NCT05096468 2023-07-06

Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.

Beijing Tiantan Hospital

Phase 2/3 Completed
90 enrolled
CNS

Pain, Postoperative, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡